FAPI Synthesis Intermediate for Lower-Polarity Industrial Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing synthesis methods for Evans blue modified FAPI (LNC1004) face challenges such as increased polarity leading to difficult separation and purification, instability of DOTA-NHS resulting in low yield and high cost, and unsuitability for industrial production.
Innovation Solution
A novel synthesis method using a key intermediate with a specific structure, involving steps like coupling, deprotection, and hydrolysis, and replacing DOTA-NHS with a more stable and less polar tri-tert-butyl DOTA-TRIS-TBU-ESTER NHS, reducing polarity and cost, and optimizing the reaction sequence for efficient large-scale production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional synthesis route using Evans blue fragment with sulfonic acid group is used, then the target product LNC1004 can be obtained, but the polarity of intermediate is increased making separation and purification difficult
Solution Approach 1:
The patent applies preliminary action by introducing a hydrophobic protecting group (tert-butyl ester) on the DOTA ring before coupling reactions. This protecting group reduces the polarity of intermediates during synthesis, enabling effective separation and purification by traditional methods such as extraction and column chromatography. The protecting group is removed in a final deprotection step to yield the desired product.
Solution Approach 2:
The patent uses a hydrophobic protecting group as an intermediary substance that temporarily modifies the polarity characteristics of the DOTA intermediate. This intermediary allows subsequent coupling reactions to proceed while maintaining separability, and is later removed to reveal the final product with the required polar properties for biological activity.
2Reliability
If DOTA-NHS is used for coupling of final fragments, then the coupling reaction can proceed, but DOTA-NHS is unstable at high temperature causing decomposition and ring opening
Solution Approach 1:
The patent performs the coupling reaction with the protected DOTA derivative (lower polarity, more stable) before removing the protecting group. This preliminary coupling step avoids the instability issues of DOTA-NHS at high temperatures, as the protected intermediate is more stable and less prone to decomposition and ring-opening side reactions.
Solution Approach 2:
The hydrophobic protecting group acts as a cushioning element that protects the DOTA ring structure from thermal decomposition and ring-opening during the coupling reaction. This prior protection prevents harmful side reactions that would otherwise occur with unstable DOTA-NHS under elevated temperatures.
3Ease of manufacture
If DOTA-NHS is used for coupling, then the reaction can proceed, but DOTA-NHS is expensive resulting in high overall cost
Solution Approach 1:
The patent employs a more cost-effective DOTA derivative with hydrophobic protecting groups instead of expensive DOTA-NHS. The protected DOTA intermediate is more stable, easier to handle, and significantly cheaper, enabling cost-effective large-scale production while maintaining product quality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly improves yield and reduces production costs, making the synthesis suitable for industrial production with higher efficiency and lower side reactions.
Implementation Method 1
step a: subjecting (S)—N-(2-(2-cyanopyrrolidin-1-yl)-2-oxoethyl)-6-(3-(piperazin-1-yl) propoxy)quinolin-4-formamide (that is, a compound II) to a reaction with succinic anhydride to obtain a compound III
Implementation Method 2
step c: subjecting the compound V to a deprotection reaction to obtain a compound VI
Implementation Method 3
step d: subjecting the compound VII to a hydrolysis reaction and treatment to obtain the intermediate having the structure of Formula I
Data Source
AI summary
The present invention provides an intermediate used for Evans blue modified FAPI synthesis, a method for preparing the intermediate, and an application of the intermediate in the synthesis of an Evans blue modified FAPI. The use of the intermediate provided by the present invention to synthesize Evans blue modified FAPI can improve the production efficiency and reduce the production cost, and the intermediate is suitable for industrial production.


